[Not Available].

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The´rapie (Paris)

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.2515/therapie/2015012PMID 27393130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological and clinical dilemmas of prescribing in co‐morbid adult attention‐deficit/hyperactivity disorder and addiction

  2014cited by this paper
• A European Community Pharmacy-Based Survey to Investigate Patterns of Prescription Fraud through Identification of Falsified Prescriptions

  2014cited by this paper
• The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse.

  2014cited by this paper
• Abuse of methylphenidate in Germany: data from spontaneous reports of adverse drug reactions.

  2014cited by this paper
• Assessment of prescription opioid intentional exposures across the rural‐urban continuum in the United States using both population and drug availability rates

  2014cited by this paper
• A Nationwide Study of Attention‐Deficit/Hyperactivity Disorder Drug Use among Adults in Iceland 2003–2012

  2014cited by this paper
• OPPIDUM surveillance program: 20 years of information on drug abuse in France

  2013cited by this paper
• Doctor shopping reveals geographical variations in opioid abuse.

  2013cited by this paper
• Prescribing of Drugs for Attention-Deficit Hyperactivity Disorder in Opioid Maintenance Treatment Patients in Norway

  2013cited by this paper
• [Not Available].

  2013cited by this paper
• The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?

  2012cited by this paper
• [Harm reduction centers ("CAARUD"): privileged places for warning signal detection in addictovigilance].

  2012cited by this paper
• Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate

  2012cited by this paper
• The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective

  2012cited by this paper
• Use of ADHD drugs in the Nordic countries: a population‐based comparison study

  2011cited by this paper
• Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets.

  2011cited by this paper
• Patterns of Methylphenidate Use and Assessment of its Abuse and Diversion in Two French Administrative Areas Using a Proxy of Deviant Behaviour Determined from a Reimbursement Database

  2011cited by this paper
• Retrospective analysis of stimulant abuse cases reported to the Swiss Toxicological Information Centre during 1997-2009.

  2010cited by this paper
• Geographic information systems and pharmacoepidemiology: using spatial cluster detection to monitor local patterns of prescription opioid abuse

  2010cited by this paper
• Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006.

  2009cited by this paper
• Increasing use of stimulants warns of potential abuse

  2008cited by this paper
• [First meeting of the French CEIP (centres d'évaluation et d'information sur la pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development].

  2008cited by this paper
• Medical Use, Illicit Use, and Diversion of Abusable Prescription Drugs

  2006cited by this paper
• [Use of the health insurance database by the centres for evaluation and information on pharmacodependance: examples, interests and future prospects].

  2004cited by this paper
• Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.

  2003cited by this paper
• Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France.

  2003cited by this paper
• Methylphenidate Abuse and Psychiatric Side Effects.

  2000cited by this paper

• From regional signal to alert in addictovigilance.

  2024cites this paper
• Détection et quantification du méthylphénidate et de l’acide ritalinique dans les matrices kératinisées

  2023cites this paper
• [Increasing methylphenidate abuse: Tracking and profiles during 13-years].

  2022cites this paper
• Addictovigilance contribution during COVID-19 epidemic and lockdown in France

  2020cites this paper
• Methods in pharmacoepidemiology.

  2019cites this paper
• [Supervised off-label prescribing of methylphenidate in adult ADHD].

  2019cites this paper
• Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution.

  2019cites this paper
• [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].

  2019cites this paper
• Reply to ‘Overuse or underuse of methylphenidate in adults in France: commentary on Pauly et al. 2018’ by Weibel et al.

  2018cites this paper
• Tamper‐resistant prescription forms for narcotics in France: Should we generalize them?

  2018cites this paper
• Medical prescriptions falsified by the patients: a 12‐year national monitoring to assess prescription drug diversion

  2018cites this paper
• Pharmaceutical cognitive doping in students: A chimeric way to get-a-head?

  2018cites this paper
• Doctor shopping of opioid analgesics relative to benzodiazepines: A pharmacoepidemiological study among 11.7 million inhabitants in the French countries.

  2018cites this paper
• Patterns and profiles of methylphenidate use both in children and adults

  2018cites this paper
• Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter"

  2017cites this paper
• [Acute psychiatric symptoms during methylphenidate intravenous injections: A case report].

  2017cites this paper
• Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey

  2017cites this paper
• Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.

  2017cites this paper
• [Pharmaceutical cognitive doping in students: a chimeric way to get-a-head?]

  2017cites this paper
• [Which psychoactives substances are found in used syringes?]

  2016cites this paper
• The consequences of drug misuse on post-marketing surveillance

  2016cites this paper